FLXN - Flexion Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $32.81. This is a potential upside of $7.05 (27.37%) from yesterday's end of day stock price of $25.76.

Flexion Therapeutics's activity chart (see below) currently has 71 price targets and 59 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31.43% with an average time for these price targets to be met of 848.85 days.

Most recent stock forecast was given by CARL BYRNES from NORTHLAND CAPITAL on 18-Nov-2021. First documented stock forecast 09-Sep-2014.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$10

3 years 11 months 6 days ago
(18-Nov-2021)

2/3 (66.67%)

$0.7 (7.53%)

1400

Buy

$10

$0.88 (9.65%)

$25

4 years 5 days ago
(20-Oct-2021)

0/3 (0%)

$10.81 (62.86%)

Buy

$10

$0.88 (9.65%)

$14

4 years 12 days ago
(13-Oct-2021)

0/7 (0%)

$5.58 (57.81%)

Hold

$12

$-13.61 (-53.14%)

$20

4 years 12 days ago
(12-Oct-2021)

3/10 (30%)

$2.62 (27.93%)

1558

Hold

$16

4 years 13 days ago
(11-Oct-2021)

2/4 (50%)

$6.62 (70.58%)

1900

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FLXN (Flexion Therapeutics) average time for price targets to be met?

On average it took 848.85 days on average for the stock forecasts to be realized with a an average price target met ratio 31.43

Which analyst has the current highest performing score on FLXN (Flexion Therapeutics) with a proven track record?

SERGE BELANGER

Which analyst has the most public recommendations on FLXN (Flexion Therapeutics)?

Serge Belanger works at NEEDHAM and has 43 price targets and 31 ratings on FLXN

Which analyst is the currently most bullish on FLXN (Flexion Therapeutics)?

Martin Auster with highest potential upside - $4.88

Which analyst is the currently most reserved on FLXN (Flexion Therapeutics)?

Gary Nachman with lowest potential downside - -$13.61

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?